pubmed-article:15918333 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C1096176 | lld:lifeskim |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
pubmed-article:15918333 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:15918333 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:15918333 | pubmed:dateCreated | 2005-5-27 | lld:pubmed |
pubmed-article:15918333 | pubmed:abstractText | Coinfection with hepatitis C virus (HCV) and HIV is not uncommon and therapies for both infections are currently available. A major drawback, however, could be a potentially higher risk for mitochondrial toxicity (MT), defined as the elevation of pancreatic enzymes or lactate levels due to the nucleoside analogue reverse transcriptase inhibitors contained in both therapies. | lld:pubmed |
pubmed-article:15918333 | pubmed:language | eng | lld:pubmed |
pubmed-article:15918333 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15918333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15918333 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15918333 | pubmed:issn | 1359-6535 | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:MartínezEsteb... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:GarcíaFelipeF | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:MallolasJosep... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:MilinkovicAna... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:LagunoMontseM | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:MurillasJavie... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:LarrousseMari... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:BigliaAlejand... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:LeonAgatheA | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:BlancoJose... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:LoncáMontseM | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:GatellJose... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:GarcíaMercede... | lld:pubmed |
pubmed-article:15918333 | pubmed:author | pubmed-author:MiróJose... | lld:pubmed |
pubmed-article:15918333 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15918333 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:15918333 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15918333 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15918333 | pubmed:pagination | 423-9 | lld:pubmed |
pubmed-article:15918333 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:meshHeading | pubmed-meshheading:15918333... | lld:pubmed |
pubmed-article:15918333 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15918333 | pubmed:articleTitle | Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients. | lld:pubmed |
pubmed-article:15918333 | pubmed:affiliation | Infectious Diseases Unit, Hospital Clinic Barcelona, Barcelona, Spain. mlaguno@clinic.ub.es | lld:pubmed |
pubmed-article:15918333 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15918333 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15918333 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15918333 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15918333 | lld:pubmed |